Method of treatment of dopamine-related dysfunction through administration of a full D1 dopamine receptor agonist and with no induction of tolerance

Details for Australian Patent Application No. 2002241889 (hide)

Owner PURDUE RESEARCH FOUNDATION UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

Inventors Nichols, David, Earl; Huang, Xuemei; Mailman, Richard, Bernard

Agent Spruson & Ferguson

Pub. Number AU-A-2002241889

PCT Pub. Number WO2002/056875

Priority 60/261,889 16.01.01 US

Filing date 16 January 2002

Wipo publication date 30 July 2002

International Classifications

A61K 031/00

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002241889

14 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002241890-OPTICAL INTERCONNECT WITH INTEGRAL REFLECTIVE SURFACE AND LENS, SYSTEM INCLUDING THE INTERCONNECT AND METHOD OF FORMING THE SAME

2002241888-COMPACT CLUTCH ASSEMBLY FEATURING DUAL SELECTIVELY-OPERATIVE ONE-WAY CLUTCHES